{"id":"W4386282236","doi":"10.1016/s2152-2650(23)00531-1","title":"POSTER: CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Fludarabine; Chronic lymphocytic leukemia; Medicine; Rituximab; Oncology; Internal medicine; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001858678,0.0001777209,0.0002680557,0.0003234004,0.001119837,0.0006523594,0.0003443758,0.0003953271,0.007472757],"category_scores_gemma":[0.0004715012,0.0001516585,0.0003416087,0.0006618422,0.0002564256,0.0001685669,0.0003414973,0.0006156795,0.0008256925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005269423,"about_ca_system_score_gemma":0.005233169,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.651105,"about_ca_topic_score_gemma":0.8133193,"domain_scores_codex":[0.9998035,0.00001458378,0.000009638935,0.0000262914,0.00004117791,0.0001048364],"domain_scores_gemma":[0.9994611,0.00002590935,0.00005711498,0.000009455232,0.0001513512,0.0002951997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002108599,0.0001544806,0.9774705,0.00004334757,0.0001296271,0.0002730084,0.0002186299,0.0001364305,0.0005326536,0.00002669703,0.00945973,0.00944628],"study_design_scores_gemma":[0.0000901181,0.0001875055,0.9972885,0.00002347298,0.00006898178,0.0001234641,0.0003170821,0.00006421444,0.0001108287,0.00001114179,0.001707351,0.000007465124],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876515,0.0008483154,0.00003864943,0.0004964842,0.00006988004,0.00004256286,0.006360139,0.00001170453,0.004480762],"genre_scores_gemma":[0.9875991,0.0005525884,0.00004046324,0.0003108503,0.00004535974,0.00002474596,0.004488742,0.000006368672,0.006931742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.348895,"threshold_uncertainty_score":0.7018993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02448581812995936,"score_gpt":0.3018563122573838,"score_spread":0.2773704941274244,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}